A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation
- 2 December 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (23) , 2935-2940
- https://doi.org/10.1016/s0960-894x(97)10117-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Selective Inhibition of Platelet-Derived Growth Factor (PDGF) Receptor Autophosphorylation and PDGF-Mediated Cellular Events by a Quinoline DerivativeExperimental Cell Research, 1997
- Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorJournal of Medicinal Chemistry, 1995
- Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.Journal of Medicinal Chemistry, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 1994
- Epidermal growth factor receptor tyrosine kinaseBiochemical Pharmacology, 1994
- A New Series of PDGF Receptor Tyrosine Kinase Inhibitors: 3-Substituted Quinoline DerivativesJournal of Medicinal Chemistry, 1994
- PDGF‐receptor protein tyrosine kinase activity in carotid artery is enhanced by injury and inhibited in vivo by tyrphostin RG 13291Drug Development Research, 1993
- Ligand-induced dimerization of the platelet-derived growth factor receptorPublished by Elsevier ,1989
- The biology of platelet-derived growth factorCell, 1986